Skip to main content

Table 1 Treatment used in groups of canine cardiac patients (ISACHC I–III)

From: Systemic inflammation in dogs with advanced-stage heart failure

Therapeutics

ISACHC I (N = 10) (n)

ISACHC II (N = 26) (n)

ISACHC III (N = 26) (n)

Salbutemol

1

  

Furosemide

 

26

21

ACE inhibitor

 

26

13

Pimobendan

1

15

14

Atenolol (beta-blocker)

 

2

4

Digoxin

 

5

9

Diltiazem (calcium-channel blocker)

 

4

4

Spironolactone

 

4

1

Potassium chloride

 

5

 

Total number of dogs with therapy

2

26

21

  1. ISACHC International Small Animal Cardiac Health Council; N number of dogs included in ISACHC group; n number of dogs per ISACHC group receiving specific cardiac drug; ACE angiotensin-converting enzyme
Back to article page

Acta Veterinaria Scandinavica

ISSN: 1751-0147